Rozatsea: novye podkhody k starym problemam

Abstract


The paper considers the etiopathogenesis of rosacea. It details the composition of 0.75% Rosex cream used to treat rosacea and the mechanism of its action. The results of treatment in 22 patients are given.

References

  1. Клинические рекомендации / Под ред. А. А. Кубановой. - М., 2007. - С. 166-171.
  2. Потекаев Н. Н. Розацеа. - СПб., 2000.
  3. Потекаев Н. Н., Демидова Л. М. // Клин. дерматол. и венерол. - 2004. - № 4. - -С. 82-84.
  4. Рыжкова Е. К. Клинико-морфологические особенности, патогенез и лечение розацеа: Автореф. дис. ... д-ра мед. наук. - М., 1976.
  5. Эрнандес Е., Марголина А., Петрухина А. Липидный барьер кожи и косметические средства. - М., 2003.
  6. Dahl M. V. / /Cutis. - 2004. - Vol. 74. - P. 21-27.
  7. Leyden J. J., Drake L. A., Lucky A. W., Miller B. H., Buko A., Weiss J. S., Dolfi F., Loesche C. The Safety and Efficacy of 0,75% Metronidazole Topical Cream For The Treatment of Rosacea: A Randomized, Double-Blind, Placebo-Controlled, Parallel Comparison. The study has been sponsored by Galderma Laboratories, Inc. 2000, Data on File.
  8. Norlen L. // J. Invest. Dermatol. - 2001. - Vol. 117, N 4. - P. 830-836.
  9. Norlen L. // J. Invest. Dermatol. - 2001. - Vol. 117, N 4. - P. 883-886.
  10. Plevig G., Kligman A. M. Acne and Rosacea. - 3-rd Ed. - Berlin, 2000.
  11. Wagner N., Berthaud C., Laffet G., Caron J.-C. // Advanc. Ther. - 1998. - Vol. 15, N 4. - P. 197-205.
  12. Wagner N., Berthaud C., Laffet G., Caron J. // J. Am. Acad. Dermatol. - 2001. - Vol. 10. - P. 459-516.
  13. Wilkin J., Kahl M. et al. // J. Am. Acad. Dermatol. - 2002. - Vol. 15. - P. 584-587.
  14. Yoo J., Reid D. C., Kimball A. B. // J. Drugs Dermatol. - 2006. - Vol. 5. - P. 317-319.

Statistics

Views

Abstract - 20

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions


Copyright (c) 2010 Volkova E.N., Osipova N.K., Rodina Y.A., Grigor'eva A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies